HIV Neurobehavioral Research Program, University of California San Diego, San Diego, California, USA.
Department of Psychiatry, Division of Geriatrics, Gerontology and Palliative Care, University of California San Diego, La Jolla, California, USA.
AIDS Patient Care STDS. 2024 May;38(5):195-205. doi: 10.1089/apc.2024.0043. Epub 2024 Apr 25.
Neurocognitive impairment and metabolic syndrome (MetS) are prevalent in persons with HIV (PWH). We examined disparities in HIV-associated neurocognitive function between Hispanic and non-Hispanic White older PWH, and the role of MetS in explaining these disparities. Participants included 116 community-dwelling PWH aged 50-75 years enrolled in a cohort study in southern California [58 Hispanic (53% Spanish speaking) and 58 age-comparable non-Hispanic White; overall group: age: = 57.9, standard deviation () = 5.7; education (years): = 13, = 3.4; 83% male, 58% AIDS, 94% on antiretroviral therapy]. Global neurocognition was derived from T-scores adjusted for demographics (age, education, sex, ethnicity, language) on a battery of 10 cognitive tests. MetS was ascertained via standard criteria that considered central obesity, and fasting elevated triglycerides, low high-density lipoprotein cholesterol and elevated glucose, or medical treatment for these conditions. Covariates examined included sociodemographic, psychiatric, substance use and HIV disease characteristics. Compared with non-Hispanic Whites, Hispanics showed worse global neurocognitive function (Cohen's = 0.56, < 0.05) and had higher rates of MetS (38% vs. 56%, < 0.05). A stepwise regression model including ethnicity and significant covariates showed Hispanic ethnicity was the sole significant predictor of worse global neurocognition ( = -3.82, = 1.27, < 0.01). A model also including MetS showed that both Hispanic ethnicity ( = -3.39, = 1.31, = 0.01) and MetS ( = -2.73, = 1.31, = 0.04) were independently associated with worse neurocognition. In conclusion, findings indicate that increased MetS is associated with worse neurocognitive function in both Hispanic and non-Hispanic White older PWH, but does not explain neurocognitive disparities. MetS remains an important target for intervention efforts to ameliorate neurocognitive dysfunction among diverse older PWH.
神经认知障碍和代谢综合征(MetS)在 HIV 感染者(PWH)中较为常见。本研究旨在探究西班牙裔和非西班牙裔白人老年 PWH 之间与 HIV 相关的神经认知功能差异,并分析代谢综合征在解释这些差异中的作用。参与者包括来自加利福尼亚南部队列研究的 116 名年龄在 50-75 岁之间的社区居住的 PWH(58 名西班牙裔(53%讲西班牙语)和 58 名年龄匹配的非西班牙裔白人;总体组:年龄: = 57.9,标准差 () = 5.7;教育(年): = 13, = 3.4;83%为男性,58%患有 AIDS,94%正在接受抗逆转录病毒治疗)。全球神经认知功能通过调整人口统计学因素(年龄、教育、性别、族裔、语言)后的 T 评分,基于 10 项认知测试得出。代谢综合征通过考虑中心性肥胖、空腹甘油三酯升高、高密度脂蛋白胆固醇降低和血糖升高,或这些疾病的医疗治疗来确定。所检查的协变量包括社会人口统计学、精神科、物质使用和 HIV 疾病特征。与非西班牙裔白人相比,西班牙裔的全球神经认知功能更差(Cohen's = 0.56, < 0.05),且代谢综合征的发生率更高(38%比 56%, < 0.05)。一个包含种族和显著协变量的逐步回归模型显示,西班牙裔种族是全球神经认知功能更差的唯一显著预测因素( = -3.82, = 1.27, < 0.01)。一个包含代谢综合征的模型也显示,西班牙裔种族( = -3.39, = 1.31, = 0.01)和代谢综合征( = -2.73, = 1.31, = 0.04)均与神经认知功能更差独立相关。总之,研究结果表明,代谢综合征增加与西班牙裔和非西班牙裔白人老年 PWH 的神经认知功能更差相关,但不能解释神经认知差异。代谢综合征仍然是改善不同种族老年 PWH 神经认知功能障碍的重要干预目标。